Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Ismael Macias"'
Autor:
Paula Ribera, Sandra Soriano, Carla Climent, Laia Vilà, Ismael Macias, Luis Antonio Fernández-Morales, Julia Giner, Enrique Gallardo, Miquel Angel Segui Palmer, Carles Pericay
Publikováno v:
Current Oncology, Vol 29, Iss 11, Pp 8565-8578 (2022)
Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors th
Externí odkaz:
https://doaj.org/article/7d7d91c40bf945f682d316bedb7b217c
Autor:
Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Virginia Arrazubi, Diego Cacho Lavin, Raquel Hernandez San Gil, Ana Custodio, Juana María Cano, Ana Fernández Montes, Oriol Mirallas, Ismael Macias Declara, Rosario Vidal Tocino, Laura Visa, María Luisa Limón, Paola Pimentel, Nieves Martínez Lago, Tamara Sauri, Marta Martín Richard, Monserrat Mangas, Mireia Gil Raga, Aitana Calvo, Pablo Reguera, Mónica Granja, Alfonso Martín Carnicero, Carolina Hernández Pérez, Paula Cerdá, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Vilma Pacheco Barcia, David Gutierrez Abad, Maribel Ruiz Martín, Jamie Weaver, Wasat Mansoor, Javier Gallego
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Trastuzumab and chemotherapy is the standard first-line treatment in human epidermal growth factor receptor 2 (HER2)-positive advanced gastro-oesophageal cancer. The objective was to develop a predictive model for overall survival (OS) an
Externí odkaz:
https://doaj.org/article/cf85aa4387664f46bdb19d331cc85d54
Autor:
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Alba Martinez-Torron, Maria Alsina, Ana Custodio, Olbia Serra, Diego Cacho Lavin, María Luisa Limón, Tamara Sauri, Flora López, Laura Visa, Mónica Granja, Nieves Martínez Lago, Virginia Arrazubi, Rosario Vidal Tocino, Raquel Hernandez, Gema Aguado, Juana María Cano, Alfonso Martín Carnicero, Monserrat Mangas, Paola Pimentel, Ana Fernández Montes, Ismael Macias Declara, Federico Longo, Avinash Ramchandani, Marta Martín Richard, Alicia Hurtado, Aitor Azkarate, Carolina Hernández Pérez, Raquel Serrano, Javier Gallego
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Trastuzumab combined with cisplatin and fluoropyrimidines, either capecitabine or 5-fluorouracile (XP/FP), is the standard first-line treatment for advanced, HER2-positive, gastric cancer patients based on the ToGA trial. Despite the lack
Externí odkaz:
https://doaj.org/article/461c7ab35c804b44a5bffb5634234fe5
Autor:
Almudena Cotes Sanchís, Javier Gallego, Raquel Hernandez, Virginia Arrazubi, Ana Custodio, Juana María Cano, Gema Aguado, Ismael Macias, Carlos Lopez, Flora López, Laura Visa, Marcelo Garrido, Nieves Martínez Lago, Ana Fernández Montes, María Luisa Limón, Aitor Azkárate, Paola Pimentel, Pablo Reguera, Avinash Ramchandani, Juan Diego Cacho, Alfonso Martín Carnicero, Mónica Granja, Marta Martín Richard, Carolina Hernández Pérez, Alicia Hurtado, Olbia Serra, Elvira Buxo, Rosario Vidal Tocino, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0235848 (2020)
BackgroundSecond-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice.Materials and methodsThe study population
Externí odkaz:
https://doaj.org/article/231893986f554dffb2d589137b70a2f6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marilina Santero, Adriana-Gabriela Meade, Anna Selva, Olga Savall-Esteve, Javier Bracchiglione, Ismael Macías, Leire Leache, Paula Cerdà, Xavier Bonfill Cosp, Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC-Study) Research Group
Publikováno v:
Systematic Reviews, Vol 13, Iss 1, Pp 1-14 (2024)
Abstract Background Highlighting the identified gaps in evidence-based research concerning advanced esophageal cancer (EC) treatment and care, this review evaluates the efficacy and safety of anticancer drugs compared to supportive care for advanced
Externí odkaz:
https://doaj.org/article/fdf0561ae8ce4cf39e3a3c81fd8c0233
Autor:
Paula Ribera, Sandra Soriano, Carla Climent, Laia Vilà, Ismael Macias, Luis Fernandez, Julia Giner, Enrique Gallardo, Miquel Àngel Seguí, Carles Pericay
BACKGROUND Since the beginning of the COVID-19 pandemic, the use of telehealth for cancer care was rapidly implemented without previous experience. Afterwards, few published studies have assessed patient’s perception with the use of telemedicine du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::235e6e01855e24517ea1978bde3ab8de
https://doi.org/10.21203/rs.3.rs-1533288/v1
https://doi.org/10.21203/rs.3.rs-1533288/v1
Autor:
Sena Valcarcel, Javier Gallego, Paula Jimenez-Fonseca, Marc Diez, Eva Martínez de Castro, Raquel Hernandez, Virginia Arrazubi, Ana Custodio, Juana María Cano, Ana Fernández Montes, Ismael Macias, Laura Visa, Aitana Calvo, Rosario Vidal Tocino, Nieves Martínez Lago, María Luisa Limón, Mónica Granja, Mireia Gil, Paola Pimentel, Lola Macia-Rivas, Carolina Hernández Pérez, Montserrat Mangas, Alfonso Martín Carnicero, Paula Cerdà, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Mª Dolores Mediano Rambla, Marta Martin Richard, Alberto Carmona-Bayonas
Publikováno v:
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
J CANCER RES CLIN
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
J CANCER RES CLIN
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
PURPOSE: This study aimed to compare ramucirumab-paclitaxel versus chemotherapy in second-line (2L) advanced gastroesophageal cancer (aGEC) based on HER2 status and analyze prognostic factors. METHODS: The study includes patients from the AGAMENON-SE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadd4716e4d425b3624cc9d2a98d8eec
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13995
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13995
Autor:
Elvira Buxó, Raquel Hernández, Marcelo Garrido, Mónica Granja, Alicia Hurtado, Olbia Serra, Rosario Vidal Tocino, Ismael Macias, Almudena Cotes Sanchís, Virginia Arrazubi, Ana Custodio, Juana María Cano, Javier Gallego, Avinash Ramchandani, Ana Montes, Paula Jiménez-Fonseca, Juan Diego Cacho, Marta Martín Richard, P. Reguera, Carlos F. Lopez, Alberto Carmona-Bayonas, Laura Visa, Carolina Hernández Pérez, Nieves Martinez Lago, Gema Aguado, María Luisa Limón, Alfonso Martín Carnicero, Paola Pimentel, Flora López, Aitor Azkarate
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0235848 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS One
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
PLoS ONE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS One
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
PLoS ONE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Background Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice. Materials and methods The study populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3ced905477a64fe5f76bc6895f20eb
https://hdl.handle.net/20.500.13003/11571
https://hdl.handle.net/20.500.13003/11571
Autor:
Elvira Buxó, Alberto Carmona-Bayonas, Antonio Viudez, Paula Cerdá, Alicia Hurtado, Aitziber Gil-Negrete, Ismael Macias, Asuncion Diaz Serrano, Ana Montes, Eva Martínez de Castro, Carlos López, Elena Asensio Martínez, Aitor Azkarate, Felipe Álvarez Manceñido, Raquel Hernández, Alfonso Martín Carnicero, Laura Visa, Federico Longo, R. Serrano, Manuel Garrido, Juana María Cano, T. García, M Mangas, Paola Pimentel, Ana Custodio, Ignacio Echavarria, Paula Jiménez-Fonseca, Avinash Ramchandani
Publikováno v:
Journal of Geriatric Oncology. 9:254-264
OBJECTIVE: Advanced gastric cancer (AGC) is a common neoplasm in older adults. Nevertheless, there are few specific management data in the literature. The aim of this study was to assess non-inferiority of survival and efficacy-related outcomes of ch